HDAC11 Inhibitors

Histone deacetylase proteins (HDACs) are a class of enzymes that remove acetyl groups (O=C-CH3) from an <ε>-N-acetyl lysine amino acid on a histone, allowing histones to wrap DNA more tightly. The deacetylation of histones is associated with transcriptional silencing. Histone deacetylase inhibitors (HDIs) have a long history of use in psychiatry and neurology as mood stabilizers and anti-epileptic. HDIs are studied as a treatment for neurodegenerative diseases and have a potential for cancer therapy. HDAC11 Inhibitors offered by Santa Cruz inhibit HDAC11 and, in some cases, other chromatin remodeling and transcription regulation related proteins. View detailed HDAC11 Inhibitor specifications, including HDAC11 Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.

PRODUCT NAME/ApplicationCASCatalog #QUANTITYPriceCitationsRATING
An HDAC1, HDAC2, HDAC4, HDAC10, and HDAC11 inhibitor
5 mg
50 mg
A potent inhibitor of HDAC1, HDAC2, HDAC3, and HDAC11
5 mg
10 mg
50 mg
PI3K/HDAC Inhibitor
An inhibitor of HDAC1, HDAC3, HDAC6, HDAC8, HDAC10, and HDAC11
5 mg
10 mg

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.